Clinical Trial Update: Patients With Necrotizing Skin and Soft Tissue Infections Managed Within the SURFAST Care Pathway.

View source ↗

Summary

This clinical trial update indicates that the SURFAST care pathway study for necrotizing soft-tissue infections is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Soft-tissue Infections

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Necrotizing Soft-tissue Infections | Status: NOT_YET_RECRUITING